Cleveland Clinic Trial Shows Novel Lipoprotein(a) Drug Did Not Reduce Major Cardiovascular Events After Nearly 5 Years
November 07, 2026
November 07, 2026
CLEVELAND, Ohio, Nov. 7 [Category: BizHospital] -- The Cleveland Clinic posted the following news release:
* * *
Cleveland Clinic Trial Shows Novel Lipoprotein(a) Drug Did Not Reduce Major Cardiovascular Events After Nearly 5 Years
*
Phase 3 HORIZON cardiovascular outcome trial examined the safety and efficacy of pelacarsen in patients with elevated lipoprotein(a) and pre-existing cardiovascular disease
Medical illustration of lipo . . .
* * *
Cleveland Clinic Trial Shows Novel Lipoprotein(a) Drug Did Not Reduce Major Cardiovascular Events After Nearly 5 Years
*
Phase 3 HORIZON cardiovascular outcome trial examined the safety and efficacy of pelacarsen in patients with elevated lipoprotein(a) and pre-existing cardiovascular disease
Medical illustration of lipo . . .